Company overview
Basic information
Company name
Biofitus vaistinė, UAB
Company code
303187387
VAT code
LT100008154113
Registered address
Vilnius, Bagušių g. 89A-2, LT-11311
Registration date
2013-11-13
Company age: 12 y. 10 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Website
https://www.biofitus.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Intermediation service activities for non-specialised retail sale
Ownership form
Private without foreign capital
UAB Biofitus vaistinė
Company code: 303187387
Address: Vilnius, Bagušių g. 89A-2, LT-11311
VAT code: LT100008154113
Download a detailed company report
Make confident decisions with all the information about Biofitus vaistinė, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Biofitus vaistine, UAB (company code 303187387) is an operational private limited liability company registered in 2013. It is classified as a private entity in the national private non-financial companies sector, with private ownership in which Lithuanian natural and legal persons hold more than 50% of authorised capital and no foreign investor capital is included. Governance is listed as CEO only. The company is based in Vilnius, at Bagušiu g. 89A-2, in Vilniaus m. sav., Vilniaus apskr. Its registered activity is G.47.91.00, intermediation service activities for non-specialised retail sale. In financial year 2025, the company generated revenue of €2.52M and net profit of €427.2K, with a profit margin of 16.9%. Revenue increased by 11.8% year on year and by 28.6% over two years. Equity stood at €1.06M, liabilities at €158.2K, and total assets at €1.21M. The company had an average of 4 employees in 2025, and so far in 2026 it has also averaged 4 employees. The average monthly wage reached €2,078.11 so far in 2026, up 4.0% year on year and 12.8% compared with two years earlier.